background treatment modalities patients hepatocellular carcinoma hcc portal vein tumor thrombus pvtt limited controversial furthermore prognosis patients extremely poor authors conducted retrospective review determine role proton beam therapy treatment patients hcc pvtt methods patients hcc tumor thrombus main trunk major branches portal vein clinical treated proton beam therapy time received proton beam irradiation patients ranged age NUMBER years NUMBER years median NUMBER years tumors ranged size NUMBER mm NUMBER mm median NUMBER mm greatest dimension total dose gray gy median NUMBER gy fractions delivered tumors including pvtt results tumors treated proton beam therapy remained controlled median NUMBER years range years NUMBER patients NUMBER patients new liver tumors outside irradiated volume years proton beam therapy NUMBER patients distant metastases consequently NUMBER patients died disease NUMBER patients salvaged therapies remaining patients alive evidence disease NUMBER years NUMBER years proton beam therapy survival rates NUMBER NUMBER years NUMBER NUMBER years median survival NUMBER years according acute radiation morbidity scoring criteria radiation therapy oncology group toxicity grade NUMBER observed conclusions proton beam therapy patients hcc pvtt feasible effective appeared improve survival local control significantly patients t3 t4n0m0 NUMBER NUMBER NUMBER NUMBER follow NUMBER NUMBER NUMBER NUMBER progression free progression free therapy related